Precipio Launches Global Expansion Strategy
24 avr. 2019 09h01 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of Precipio’s global pathology services. The services are...
Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer
18 avr. 2019 08h45 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced today that Mr. Ori Karev has joined the company as its Chief Strategy...
Precipio’s HemeScreen™ Adopted by Methodist Health
03 avr. 2019 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that Methodist Hospital, located in Memphis, TN, has selected...
Inspirata and Ohio State University Continue to Break Digital Pathology Barriers
18 mars 2019 07h30 HE
|
Inspirata, Inc.
Columbus, Ohio, March 18, 2019 (GLOBE NEWSWIRE) -- Less than one year ago Inspirata announced that their digital pathology solution was used to make the first-ever primary digital diagnosis in the...
Continued ICP Orders From Japanese Customers
05 mars 2019 07h40 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it continues to receive both new and repeat business from...
Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis
29 janv. 2019 07h47 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced a recent radio show interview of Ilan Danieli, Precipio’s CEO, on...
Inspirata Join Global Thought-Leaders in Pathology and Diagnostics at ‘Frontiers in Laboratory Medicine 2019’ in Birmingham, January 29-30
24 janv. 2019 01h00 HE
|
Inspirata, Inc.
London, United Kingdom, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata® Europe, Ltd. confirmed today its participation in Frontiers...
Precipio Reports Strong Mid-Quarter Growth
12 déc. 2018 08h15 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that based on metrics observed in its October and November revenue...
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
16 oct. 2018 07h47 HE
|
Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
Interpace Diagnostics Enters into Agreement with Renowned Integrated Health System
04 oct. 2018 06h55 HE
|
Interpace Diagnostics Group, Inc.
Agreement with Piedmont Healthcare Covers Company’s Pancreatic Cancer Test PARSIPPANY, NJ, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) reported today that it has...